Intro

This chapter explores AstraZeneca's decision to spin off its China operations as a strategy to manage risks from U.S.-China tensions. It also examines the broader geopolitical context and its impact on corporate strategies in a complex international environment.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app